EP
CLB icon

Essential Partners’s Core Laboratories CLB Stock Holding History

Essential Partners’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.2K Buy
330
+258
+358% +$2.99K ﹤0.01% 1724
2026
Q2 		$839 Sell
72
-50
-41% -$714 ﹤0.01% 2317
2026
Q1 		$2.05K Hold
122
– – ﹤0.01% 1999
2025
Q4 		$1.96K Buy
122
+82
+205% +$1.22K ﹤0.01% 1808
2025
Q3 		$494 Buy
+40
New +$469 ﹤0.01% 2207

Other funds holding CLB

FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
HCA
Harpswell Capital Advisors Yarmouth, Maine $152M AUM 8.39% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Essential Partners's CLB Position: Q3 2026 in Review

Essential Partners increased its Core Laboratories (CLB) stake by 358% in Q3 2026, buying an estimated $2.99K and bringing the position to 330 shares worth $3.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1724.

Essential Partners first reported a position in CLB in Q3 2025 and has held it in 5 quarters since. 5 funds tracked by Wall St. Rank hold CLB as of Q3 2026.

  • Essential Partners held 330 shares of Core Laboratories worth $3.2K as of Q3 2026.
  • Essential Partners bought 258 Core Laboratories shares in Q3 2026, an estimated $2.99K.
  • Core Laboratories made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #1724 holding.
  • Essential Partners first reported a position in Core Laboratories in Q3 2025 and has held it in 5 quarters since.
  • 5 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.